Phoenix Rising tells QMUL: release the PACE trial data
Mark Berry, Acting CEO of Phoenix Rising, presents the Board of Directors’ open letter to Queen Mary University of London (QMUL) urging them to release the PACE trial data, and hopes that other non-UK organisations will join British charities in the same request...
Discuss the article on the Forums.

IOM has very weak quality control

Discussion in 'Institute of Medicine (IOM) Government Contract' started by Andrew, Nov 28, 2013.

  1. Andrew

    Andrew Senior Member

    Messages:
    2,123
    Likes:
    1,858
    Los Angeles, USA
    The way their process is set up.

    Let's say we found clearly incorrect information in an early draft from the panel, and we showed them evidence that proved it, but they said "Well, the CDC says otherwise, and even if they don't offer evidence, we can't see any reason why they would lie." And then they refuse to correct their decision. Nothing can be done. Even if the entire IOM staff and review board agrees with us, the mistakes will not be corrected. The panel has ultimate authority, right or wrong. And the IOM set it up to work this way.
     
  2. peggy-sue

    peggy-sue

    Messages:
    2,623
    Likes:
    3,220
    Scotland
    It's the same with governments here.
    They employ outside experts to give them scientific evidence - and if the government doesn't like the evidence, they sack the experts and carry on ignoring the facts.
     

See more popular forum discussions.

Share This Page